目的探讨康莱特注射液联合介入化疗栓塞治疗中、晚期原发性肝癌的疗效。
Objective To evaluate the efficacy of KanLaite injection combined with chemoembolization on primary middle and advanced stage liver cancer.
目的利用癌症痛动物模型，研究和评价康莱特注射液治疗癌症疼痛的疗效。
Objective To study and evaluate the effects of Kanglaite Injection (KLT) in rat model of cancer pain.
目的探讨康莱特注射液联合介入化疗栓塞治疗中、晚期原发性肝癌的疗效。
Objective: To study the therapeutic effect of preoperative interventional chemo-embolization in treating renal cell carcinoma.
结论：康莱特注射液与健择对移植于裸鼠的人胰腺癌的抑制作用具有协同效应。
CONCLUSION: Kanglaite combined with Gemzar could inhibit the growth of the transplanted human pancreatic carcinoma in nude mice and has synergistic effect.
目的探讨康莱特注射液联合化疗对晚期非小细胞肺癌(NSCLC)患者生活质量改善的临床意义。
Objective it is to discuss the clinical significance of Kanglaite injection combined with chemotherapy on life quality improved in non-small cell lung cancer (NSCLC) patients in advanced stage.
结论全反式维甲酸和康莱特注射液可逆转家兔颊黏膜鳞状上皮癌前病变，有可能成为新的化学阻断干预药物。
Conclusion ATRA and Kanglaite injection can reverse precancerous squamous epithelial lesions in rabbits and may be used as new intervention chemicals.
结论全反式维甲酸和康莱特注射液可逆转家兔颊黏膜鳞状上皮癌前病变，有可能成为新的化学阻断干预药物。
Conclusion ATRA and Kanglaite injection can reverse precancerous squamous epithelial lesions in rabbits and may be used as new intervention chemicals.
应用推荐